| Biomarkers in hepatocellular carcinoma: diagnosis, prognosis and treatment response assessment F Piñero, M Dirchwolf, MG Pessôa Cells 9 (6), 1370, 2020 | 392 | 2020 |
| Liver transplantation for hepatocellular carcinoma: evaluation of the alpha‐fetoprotein model in a multicenter cohort from Latin America F Piñero, M Tisi Baña, EC de Ataide, S Hoyos Duque, S Marciano, ... Liver International 36 (11), 1657-1667, 2016 | 96 | 2016 |
| Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation M Iavarone, F Invernizzi, C Czauderna, M Sanduzzi‐Zamparelli, S Bhoori, ... American Journal of Transplantation 19 (11), 3176-3184, 2019 | 83 | 2019 |
| Treatment with direct‐acting antivirals for HCV decreases but does not eliminate the risk of hepatocellular carcinoma F Piñero, M Mendizabal, E Ridruejo, F Herz Wolff, B Ameigeiras, ... Liver International 39 (6), 1033-1043, 2019 | 81 | 2019 |
| Disease progression in patients with hepatitis C virus infection treated with direct-acting antiviral agents M Mendizabal, F Piñero, E Ridruejo, FH Wolff, M Anders, V Reggiardo, ... Clinical Gastroenterology and Hepatology 18 (11), 2554-2563. e3, 2020 | 69 | 2020 |
| A different gut microbiome linked to inflammation found in cirrhotic patients with and without hepatocellular carcinoma F Pinero, M Vazquez, P Baré, C Rohr, M Mendizabal, M Sciara, C Alonso, ... Annals of hepatology 18 (3), 480-487, 2019 | 65 | 2019 |
| Assessing the impact of COVID-19 on liver cancer management (CERO-19) S Muñoz-Martínez, V Sapena, A Forner, JC Nault, G Sapisochin, ... JHEP reports 3 (3), 100260, 2021 | 53 | 2021 |
| A novel synergistic combination of cyclophosphamide and gene transfer of interleukin-12 eradicates colorectal carcinoma in mice M Malvicini, M Rizzo, L Alaniz, F Piñero, M García, C Atorrasagasti, ... Clinical Cancer Research 15 (23), 7256-7265, 2009 | 53 | 2009 |
| Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission M Mendizabal, F Pinero, E Ridruejo, M Anders, MD Silveyra, A Torre, ... Annals of Hepatology 21, 100298, 2021 | 51 | 2021 |
| Fatty liver disease, an emerging etiology of hepatocellular carcinoma in Argentina F Piñero, J Pages, S Marciano, N Fernández, J Silva, M Anders, A Zerega, ... World journal of hepatology 10 (1), 41, 2018 | 51 | 2018 |
| Epidemiology of hepatitis E in South-East Europe in the" One Health" concept A Mrzljak, P Dinjar-Kujundzic, L Jemersic, J Prpic, L Barbic, V Savic, ... World journal of gastroenterology 25 (25), 3168, 2019 | 41 | 2019 |
| A changing etiologic scenario in liver transplantation for hepatocellular carcinoma in a multicenter cohort study from Latin America F Pinero, P Costa, YL Boteon, SH Duque, S Marciano, M Anders, A Varón, ... Clinics and Research in Hepatology and Gastroenterology 42 (5), 443-452, 2018 | 32 | 2018 |
| Hepatocellular carcinoma in Latin America: Diagnosis and treatment challenges F Piñero, J Poniachik, E Ridruejo, M Silva World Journal of Gastroenterology 24 (37), 4224, 2018 | 26 | 2018 |
| Latin American Liver Research, Education and Awareness Network (LALREAN) F Piñero, M Tisi Baña, EC de Ataide, S Hoyos Duque, S Marciano, ... Liver transplantation for hepatocellular carcinoma: evaluation of the alpha …, 2016 | 25 | 2016 |
| Regorafenib efficacy after sorafenib in patients with recurrent hepatocellular carcinoma after liver transplantation: a retrospective study M Iavarone, F Invernizzi, T Ivanics, S Mazza, C Zavaglia, ... Liver Transplantation 27 (12), 1767-1778, 2021 | 24 | 2021 |
| Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection M Mendizabal, E Ridruejo, F Pinero, M Anders, M Padilla, LG Toro, ... Annals of Hepatology 25, 100350, 2021 | 24 | 2021 |
| Sequencing of systemic treatment for hepatocellular carcinoma: Second line competitors F Piñero, M Silva, M Iavarone World Journal of Gastroenterology 26 (16), 1888, 2020 | 23 | 2020 |
| Liver disease and dyslipidemia as a manifestation of lysosomal acid lipase deficiency (LAL-D). Clinical and diagnostic aspects, and a new treatment. An update. L Bay, C Cañero Velasco, M Ciocca, A Cotti, M Cuarterolo, A Fainboim, ... Sociedad Argentina de Pediatría., 2017 | 23 | 2017 |
| Identifying patients at higher risk of hepatocellular carcinoma recurrence after liver transplantation in a multicenter cohort study from Argentina F Piñero, S Marciano, M Anders, FO Ganem, A Zerega, J Cagliani, ... European journal of gastroenterology & hepatology 28 (4), 421-427, 2016 | 22 | 2016 |
| International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria H Degroote, F Piñero, C Costentin, A Notarpaolo, IF Boin, K Boudjema, ... Jhep Reports 3 (5), 100331, 2021 | 20 | 2021 |
